Malin Corporation | MLC - Ebit

Stock Price
7.60
Daily Change
0 0%
Monthly
0%
Yearly
-24.00%
Q1 Forecast
7.37

Malin Corporation reported EUR-1.1M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
ALKERMES USD -10.95M 100.03M Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Eurofins Scientific SE EUR 530.9M 36.9M Jun/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Lonza CHF 673M 54M Jun/2025
Malin Corporation EUR -1.1M 300K Dec/2024
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Ovoca Bio EUR -5.65M 3.45M Jun/2022
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025